Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | ERAP2 | Q6P179 | 2/20 | 0.68 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.67 |
| ▸ | ACE | P12821 | 4/20 | 0.67 |
| ▸ | ITGB2 | P05107 | 6/20 | 0.66 |
| ▸ | ICAM1 | P05362 | 6/20 | 0.66 |
| ▸ | ITGAL | P20701 | 6/20 | 0.66 |
| ▸ | POLB | P06746 | 2/20 | 0.65 |
| ▸ | MEN1 | O00255 | 1/20 | 0.65 |
| ▸ | HTT | P42858 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.65 |
| ▸ | TP53 | P04637 | 1/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30051539 | 1.00 | ALOX15 (0.68) | ALOX15ERAP2P2RY14ACEITGB2 | |
| SCHEMBL1407978 | 1.00 | ALOX15 (0.68) | ALOX15ERAP2P2RY14ACEITGB2 | |
| Water SCHEMBL28029902 | 0.99 | ERAP2 (0.67) | ALOX15ERAP2P2RY14ACEITGB2 | |
| Water SCHEMBL28029903 | 0.99 | ERAP2 (0.67) | ALOX15ERAP2P2RY14ACEITGB2 | |
| Urea SCHEMBL2597753 | 0.97 | ERAP2 (0.65) | ALOX15ERAP2P2RY14ACEITGB2 | |
| Urea SCHEMBL2597752 | 0.97 | ERAP2 (0.65) | ALOX15ERAP2P2RY14ACEITGB2 | |
| SCHEMBL30051742 | 0.95 | ACE (0.68) | ALOX15ERAP2P2RY14ACEITGB2 | |
| SCHEMBL15757296 | 0.92 | ERAP2 (0.62) | ALOX15ERAP2P2RY14ACEITGB2 | |
| SCHEMBL29352080 | 0.92 | ERAP2 (0.62) | ALOX15ERAP2P2RY14ACEITGB2 | |
| SCHEMBL15757291 | 0.92 | ERAP2 (0.62) | ALOX15ERAP2P2RY14ACEITGB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 270 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | HAIKOU QIAOSHUI UNITED TECHNOLOGY CO. LTD. (CN) | 2026-03-12 | — | — | US | claimed |
| EP-4695413-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | Ohio State Innovation Foundation (US) | 2026-02-18 | — | — | EP | claimed |
| US-20250345469-A1 | COMPOSITION COMPRISING A RAPALOG AND A RADIOLABELLED GASTRIN ANALOGUE, IN PARTICULAR FOR USE IN THE TREATMENT AND/OR DIAGNOSIS OF CCKB RECEPTOR POSITIVE CANCER OR TUMORS | SCHERRER INST PAUL (CH) | 2025-11-13 | — | — | US | claimed |
| US-12185635-B2 | Piezoelectric peptide-based materials and piezoelectric devices containing same | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2024-12-31 | — | — | US | claimed |
| CN-118987163-A | Use of sardine peptide-containing composition for improving atopic dermatitis symptoms | 海口桥水联合科技有限责任公司 | 2024-11-22 | — | — | CN | claimed |
| WO-2024235082-A1 | USE OF SARDINE PEPTIDE COMPOSITION IN DRUG FOR TREATING ALLERGIC RHINITIS | 海口桥水联合科技有限责任公司 | 2024-11-21 | — | — | WO | claimed |
| CN-118406439-B | Chemical mechanical polishing composition and application thereof in tungsten chemical mechanical polishing | 万华化学集团电子材料有限公司 | 2024-10-18 | — | — | CN | claimed |
| WO-2024216031-A1 | PHOSPHONOALANINE OLIGOPEPTIDES AND METHODS OF MAKING AND USE THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2024-10-17 | — | — | WO | claimed |
| CN-115124591-B | Spirulina platensis phycocyanin angiotensin converting enzyme inhibitory peptide and preparation method and application thereof | 齐鲁工业大学 | 2024-09-13 | — | — | CN | claimed |
| CN-115746092-B | Spirulina platensis phycocyanin active peptide with antioxidant and anti-aging activities and application thereof | 齐鲁工业大学 | 2024-08-13 | — | — | CN | claimed |
| EP-0500745-A1 | METAL-PEPTIDE COMPOSITIONS AND COSMETIC METHODS FOR STIMULATING HAIR GROWTH | PROCYTE CORPORATION (US) | 1992-09-02 | — | — | EP | claimed |
| EP-0495877-A1 | METHODS AND COMPOSITIONS FOR HEALING BONE. | PROCYTE CORP (US) | 1992-07-29 | — | — | EP | claimed |
| EP-0234186-B1 | USE OF OLIGOPEPTIDS FOR THE TREATMENT OF CEREBRAL DISORDERS | Fresenius AG (DE) | 1991-11-06 | — | — | EP | claimed |
| WO-1991014437-A2 | USE OF COPPER(II) CONTAINING COMPOUNDS TO ACCELERATE WOUND HEALING | PROCYTE CORPORATION (US) | 1991-10-03 | — | — | WO | claimed |
| WO-1991012267-A1 | ANTI-OXIDATIVE AND ANTI-INFLAMMATORY METAL:PEPTIDE COMPLEXES AND USES THEREOF | PROCYTE CORPORATION (US) | 1991-08-22 | — | — | WO | claimed |
| WO-1991007431-A1 | METAL-PEPTIDE COMPOSITIONS AND METHODS FOR STIMULATING HAIR GROWTH | PROCYTE CORPORATION (US) | 1991-05-30 | — | — | WO | claimed |
| WO-1991005797-A1 | METHODS AND COMPOSITIONS FOR HEALING BONE | PROCYTE CORPORATION (US) | 1991-05-02 | — | — | WO | claimed |
| US-4849408-A | GLYCYLTRYPTOPHAN, ANTIDEPRESSANTS, SEDATIVES | (501) FRESENIUS AG (DE) | 1989-07-18 | — | — | US | claimed |
| EP-0234186-A1 | Use of oligopeptids for the treatment of cerebral disorders | Fresenius AG (DE) | 1987-09-02 | — | — | EP | claimed |
| US-4085207-A | AND AT LEAST ONE OF N-ACYL-L-TRYPTOPHANS AND N-ACYL-L-PROLINES | OTSUKA PHARMACEUTICAL FACTORY, INC. (JA) | 1978-04-18 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250345469-A1 | COMPOSITION COMPRISING A RAPALOG AND A RADIOLABELLED GASTRIN ANALOGUE, IN PARTICULAR FOR USE IN THE TREATMENT AND/OR DIAGNOSIS OF CCKB RECEPTOR POSITIVE CANCER OR TUMORS | CCKBR, GRPR, CCKAR | ALOX15 3125/4885ERAP2 545/4885P2RY14 692/4885 |
| US-20260069651-A1 | Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis | VIP, ANPEP, RNPEP | ALOX15 3007/4885ERAP2 118/4885P2RY14 1529/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.